• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1型大麻素受体在人黑色素瘤细胞中的促肿瘤作用。

Tumor-promoting effects of cannabinoid receptor type 1 in human melanoma cells.

作者信息

Carpi Sara, Fogli Stefano, Polini Beatrice, Montagnani Valentina, Podestà Adriano, Breschi Maria Cristina, Romanini Antonella, Stecca Barbara, Nieri Paola

机构信息

Department of Pharmacy, University of Pisa, Pisa, Italy.

Department of Pharmacy, University of Pisa, Pisa, Italy.

出版信息

Toxicol In Vitro. 2017 Apr;40:272-279. doi: 10.1016/j.tiv.2017.01.018. Epub 2017 Jan 26.

DOI:10.1016/j.tiv.2017.01.018
PMID:28131817
Abstract

The role of endocannabinoid system in melanoma development and progression is actually not fully understood. This study was aimed at clarifying whether cannabinoid-type 1 (CB1) receptor may function as tumor-promoting or -suppressing signal in human cutaneous melanoma. CB1 receptor expression was measured in human melanoma cell lines by real-time PCR. A genetic deletion of CB1 receptors in selected melanoma cells was carried out by using three different short hairpin RNAs (shRNAs). Performance of target gene silencing was verified by real-time PCR and Western blot. The effects of CB1 receptor silencing on cell growth, clonogenicity, migration capability, cell cycle progression, and activation of mitogenic signals was tested. Lentiviral shRNAs vectors targeting different regions of the human CB1 gene led to a significant reduction in CB1 receptor mRNA and a near complete loss of CB1 receptor protein, compared to control vector (LV-c). The number of viable cells, the colony-forming ability and cell migration were significantly reduced in cells transduced with CB1 lentiviral shRNAs compared to LV-c. Cell cycle analyses showed arrest at G1/S phase. p-Akt and p-ERK expression were decreased in transduced versus control cells. Findings of this study suggest that CB1 receptor might function as tumor-promoting signal in human cutaneous melanoma.

摘要

内源性大麻素系统在黑色素瘤发生和发展中的作用实际上尚未完全明确。本研究旨在阐明1型大麻素(CB1)受体在人类皮肤黑色素瘤中是作为肿瘤促进信号还是肿瘤抑制信号发挥作用。通过实时PCR检测人类黑色素瘤细胞系中CB1受体的表达。利用三种不同的短发夹RNA(shRNA)对选定的黑色素瘤细胞中的CB1受体进行基因敲除。通过实时PCR和蛋白质免疫印迹法验证靶基因沉默的效果。测试了CB1受体沉默对细胞生长、克隆形成能力、迁移能力、细胞周期进程和有丝分裂信号激活的影响。与对照载体(LV-c)相比,靶向人类CB1基因不同区域的慢病毒shRNA载体导致CB1受体mRNA显著减少,CB1受体蛋白几乎完全丧失。与LV-c相比,用CB1慢病毒shRNA转导的细胞中活细胞数量、集落形成能力和细胞迁移显著降低。细胞周期分析显示在G1/S期停滞。转导细胞与对照细胞相比,p-Akt和p-ERK表达降低。本研究结果表明,CB1受体可能在人类皮肤黑色素瘤中作为肿瘤促进信号发挥作用。

相似文献

1
Tumor-promoting effects of cannabinoid receptor type 1 in human melanoma cells.1型大麻素受体在人黑色素瘤细胞中的促肿瘤作用。
Toxicol In Vitro. 2017 Apr;40:272-279. doi: 10.1016/j.tiv.2017.01.018. Epub 2017 Jan 26.
2
Anandamide drives cell cycle progression through CB1 receptors in a rat model of synchronized liver regeneration.在同步肝再生大鼠模型中,花生四烯乙醇胺通过CB1受体驱动细胞周期进程。
J Cell Physiol. 2015 Dec;230(12):2905-14. doi: 10.1002/jcp.24959.
3
Synthetic and endogenous cannabinoids protect retinal neurons from AMPA excitotoxicity in vivo, via activation of CB1 receptors: Involvement of PI3K/Akt and MEK/ERK signaling pathways.合成大麻素和内源性大麻素通过激活CB1受体在体内保护视网膜神经元免受AMPA兴奋性毒性:PI3K/Akt和MEK/ERK信号通路的参与。
Exp Eye Res. 2015 Jul;136:45-58. doi: 10.1016/j.exer.2015.05.007. Epub 2015 May 16.
4
Cannabinoid receptors as novel targets for the treatment of melanoma.大麻素受体作为治疗黑色素瘤的新靶点。
FASEB J. 2006 Dec;20(14):2633-5. doi: 10.1096/fj.06-6638fje. Epub 2006 Oct 25.
5
CB1 cannabinoid receptors modulate kinase and phosphatase activity during extinction of conditioned fear in mice.CB1大麻素受体在小鼠条件性恐惧消退过程中调节激酶和磷酸酶活性。
Learn Mem. 2004 Sep-Oct;11(5):625-32. doi: 10.1101/lm.77904.
6
Cannabinoid receptors in conjunctival epithelium: identification and functional properties.结膜上皮中的大麻素受体:鉴定与功能特性
Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4535-44. doi: 10.1167/iovs.07-1319. Epub 2008 Jun 19.
7
Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease.在亨廷顿舞蹈症转基因小鼠模型中,CB1受体和内源性大麻素水平的改变先于运动症状出现。
Neuroscience. 2009 Sep 29;163(1):456-65. doi: 10.1016/j.neuroscience.2009.06.014. Epub 2009 Jun 10.
8
Rimonabant inhibits proliferation, collagen secretion and induces apoptosis in hepatic stellate cells.利莫那班抑制肝星状细胞的增殖、胶原蛋白分泌并诱导其凋亡。
Hepatogastroenterology. 2014 Oct;61(135):2052-61.
9
Interaction of endocannabinoid system and steroid hormones in the control of colon cancer cell growth.内源性大麻素系统与甾体激素在结肠癌细胞生长调控中的相互作用。
J Cell Physiol. 2012 Jan;227(1):250-8. doi: 10.1002/jcp.22727.
10
Cannabinoid receptor 1 and acute resistance exercise--In vivo and in vitro studies in human skeletal muscle.大麻素受体1与急性抗阻运动——人体骨骼肌的体内和体外研究
Peptides. 2015 May;67:55-63. doi: 10.1016/j.peptides.2015.03.007. Epub 2015 Mar 18.

引用本文的文献

1
Evaluation of the metabolic activity, angiogenic impacts, and GSK-3β signaling of the synthetic cannabinoid MMB-2201 on human cerebral microvascular endothelial cells.合成大麻素MMB-2201对人脑血管内皮细胞的代谢活性、血管生成影响及GSK-3β信号传导的评估
J Cannabis Res. 2024 Dec 20;6(1):43. doi: 10.1186/s42238-024-00255-7.
2
Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases.大麻素化合物作为治疗非癌症皮肤疾病的一种药物治疗选择。
Cells. 2022 Dec 16;11(24):4102. doi: 10.3390/cells11244102.
3
Cannabinoids as Prospective Anti-Cancer Drugs: Mechanism of Action in Healthy and Cancer Cells.
大麻素类药物作为有前景的抗癌药物:在健康细胞和癌细胞中的作用机制。
Adv Exp Med Biol. 2023;1410:145-169. doi: 10.1007/5584_2022_748.
4
The Synthetic Cannabinoid URB447 Exerts Antitumor and Antimetastatic Effect in Melanoma and Colon Cancer.合成大麻素URB447在黑色素瘤和结肠癌中发挥抗肿瘤和抗转移作用。
Pharmaceuticals (Basel). 2022 Sep 20;15(10):1166. doi: 10.3390/ph15101166.
5
Complementary and alternative therapies in skin cancer a literature review of biologically active compounds.皮肤癌的补充和替代疗法:生物活性化合物的文献综述。
Dermatol Ther. 2022 Nov;35(11):e15842. doi: 10.1111/dth.15842. Epub 2022 Sep 27.
6
Topical cannabidiol (CBD) in skin pathology - A comprehensive review and prospects for new therapeutic opportunities.局部应用大麻二酚(CBD)在皮肤病理学中的应用——全面综述及新治疗机会展望。
S Afr Fam Pract (2004). 2022 May 30;64(1):e1-e4. doi: 10.4102/safp.v64i1.5493.
7
Impact of Cannabinoid Compounds on Skin Cancer.大麻素化合物对皮肤癌的影响。
Cancers (Basel). 2022 Mar 31;14(7):1769. doi: 10.3390/cancers14071769.
8
Anandamide-Modulated Changes in Metabolism, Glycosylation Profile and Migration of Metastatic Melanoma Cells.花生四烯乙醇胺调节转移性黑色素瘤细胞的代谢、糖基化谱及迁移变化。
Cancers (Basel). 2022 Mar 10;14(6):1419. doi: 10.3390/cancers14061419.
9
Cannabinoids and their derivatives in struggle against melanoma.大麻素及其衍生物在对抗黑色素瘤中的作用。
Pharmacol Rep. 2021 Dec;73(6):1485-1496. doi: 10.1007/s43440-021-00308-1. Epub 2021 Jul 15.
10
Neuroendocrine Factors in Melanoma Pathogenesis.黑色素瘤发病机制中的神经内分泌因素
Cancers (Basel). 2021 May 10;13(9):2277. doi: 10.3390/cancers13092277.